Amy Sparling

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Health Sciences Centre(Current)

Northwestern University

Alexion Pharmaceuticals (United States)

Sunnybrook Health Science Centre

Amy Sparling is an author at Health Sciences Centre specializing in clinical pharmacology, patient preference measurement, and paroxysmal nocturnal hemoglobinuria therapy.

Publications per year

2020–2020

Publications

Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria

John Devin Peipert, Austin Kulasekararaj, Anna Gayà et al. · PLoS ONE · 2020 · 48 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

<p>Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©)</p>

Karen Kaiser, Susan Yount, Christa E. Martens et al. · Patient Preference and Adherence · 2020 · 16 citations · Full text

Medicine, Hematology, Pharmacology +13

1–2 of 2